GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.39% | 203.46% | |||
| Total Other Revenue | -0.45% | 48.18% | |||
| Total Revenue | -0.42% | 1,198.16% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -0.42% | 1,198.16% | |||
| SG&A Expenses | -0.43% | 9.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.43% | -26.67% | |||
| Operating Income | 0.43% | 35.31% | |||
| Income Before Tax | 0.43% | 25.21% | |||
| Income Tax Expenses | 0.00% | 145.10% | |||
| Earnings from Continuing Operations | 0.43% | 25.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.43% | 25.05% | |||
| EBIT | 0.43% | 35.31% | |||
| EBITDA | 0.43% | 35.74% | |||
| EPS Basic | 0.57% | 42.86% | |||
| Normalized Basic EPS | 0.91% | 43.01% | |||
| EPS Diluted | 0.57% | 42.86% | |||
| Normalized Diluted EPS | 0.91% | 43.01% | |||
| Average Basic Shares Outstanding | 0.00% | 31.29% | |||
| Average Diluted Shares Outstanding | 0.00% | 31.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||